Ionis Pharmaceuticals Inc. Common Stock vs Rivian Automotive, Inc. — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.28 (market cap $7.10B), while Rivian Automotive, Inc. trades at $12.85 (market cap $18.75B). The key difference: Rivian Automotive, Inc. is far larger — about 2.6× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Rivian Automotive, Inc. is more actively traded (23,581,407 versus 2,027,457). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Rivian Automotive, Inc. for 61 Days on average.
| IONS | RIVN | |
|---|---|---|
Market Cap | $7.10B | $18.75B |
Volume | 2,027,457 | 23,581,407 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $22.45 |
52-Week Low | $42.38 | $12.50 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $6.66B | $18.79B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →